Can a rapid drug combo save kidneys? new trial aims to find out
NCT ID NCT07547878
First seen Apr 23, 2026 · Last updated May 21, 2026 · Updated 9 times
Summary
This study tests whether starting four approved kidney disease medicines within 8 weeks is safe and effective for people with type 2 diabetes and chronic kidney disease. About 64 adults will be randomly assigned to either the rapid-start approach or usual care. Researchers will track kidney function, potassium levels, and how many participants can stay on all four medicines for 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor Scott and White Medical Center- Temple
Temple, Texas, 76508, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.